Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Sunday, September 30, 2012
Friday, September 28, 2012
People, pets still troubled by drug shortages say doctors, veterinarians
Published: Thursday, September 27, 2012, 7:45 PM Updated: Thursday, September 27, 2012, 9:55 PM
By Cristina Rojas/Hunterdon County Democrat
Even as the Federal Drug Administration has made strides to prevent drug shortages, doctors, pharmacists and veterinarians still find themselves scrambling to fill prescriptions when drugs have been recalled, discontinued or back ordered. To read rest of the article click here.
Even as the Federal Drug Administration has made strides to prevent drug shortages, doctors, pharmacists and veterinarians still find themselves scrambling to fill prescriptions when drugs have been recalled, discontinued or back ordered. To read rest of the article click here.
Thursday, September 27, 2012
American Horse Daily: Consider the Source
American Horse Daily has an article today, September 27, 2012, entitled Consider the Source, When you're seeking horse health information, go to a reliable source. To read the entire article click here.
Wednesday, September 26, 2012
FDA Urged to Speed Approval of Drugs
LIFE & CULTURESeptember 25, 2012, 7:06 p.m. ET
By THOMAS M. BURTON
A White House advisory body on Tuesday unveiled a plan to double the number of new prescription drugs that go on the market each year by more quickly approving drugs to treat high-risk patients.
The President's Council of Advisors on Science and Technology urged the Food and Drug Administration to expand its use of faster drug approvals to a wider range of diseases. The council suggested the FDA could begin to approve drugs that may help only a narrow and high-risk patient population, such as people who are morbidly obese, under what the council called "special medical use" approvals.
The advisory report gave few details of what new laws or regulations might be required to limit a new drug's use to such populations. Historically, the FDA doesn't attempt to police how doctors use drugs, though companies' marketing is restricted to the conditions specified on the label.
To read the remainder of the article click here
Tuesday, September 25, 2012
Johnson City cancer center business manager pleads guilty to buying unapproved drugs
Updated September 19, 2012 8:41 PM
Read more: http://www.johnsoncitypress.com/News/article.php?id=102462#ixzz27VZ118zG
Subscribe to:
Posts (Atom)